Osteoarthritis IV: Clinical therapeutic trials and treatment

No abstract is available for this paper.

• Publication year

  2002

• Venue

  InflammoPharmacology

• Publication date

  2002-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1163/156856002320752017
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The relative toxicity of nonsteroidal antiinflammatory drugs.

  2010cited by this paper
• Severe liver damage caused by therapeutic doses of acetaminophen.

  2009cited by this paper
• Omeprazole ameliorates aspirin-induced gastroduodenal injury

  2005cited by this paper
• Pharmacokinetic interactions of alcohol and acetylsalicylic acid

  2004cited by this paper
• The effect of probenecid on paracetamol metabolism and pharmacokinetics

  2004cited by this paper
• NSAID-induced gastrointestinal damage: the biochemical consequences of the 'ion trapping' hypothesis

  2004cited by this paper
• Gene therapy for arthritis.

  2003cited by this paper
• Osteoarthritis II: Pathology and pathogenesis

  2002cited by this paper
• Bone morphogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destruction.

  2002cited by this paper
• UvA-DARE (Digital Academic Repository) Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?

  2002cited by this paper
• Health-related quality of life in early rheumatoid arthritis: impact of disease and treatment response.

  2002cited by this paper
• The verdict favors nonsteroidal antiinflammatory drugs for treatment of osteoarthritis and a plea for more evidence on other treatments.

  2001cited by this paper
• THE COX-2 INHIBITOR ETORICOXIB DID NOT ALTER THE ANTI-PLATELET EFFECTS OF LOW-DOSE ASPIRIN IN HEALTHY VOLUNTEERS.

  2001cited by this paper
• IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.

  2001cited by this paper
• Regional nerve blocks : textbook and color atlas

  2001cited by this paper
• Use of acetaminophen in alcoholic patients: comment on the 2000 update of the American College of Rheumatology recommendations for management of hip and knee osteoarthritis.

  2001cited by this paper
• Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2.

  2001cited by this paper
• Nonsteroidal anti-inflammatory drugs: overused or underused in osteoarthritis?

  2001cited by this paper
• Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets.

  2001cited by this paper
• Review of gastrointestinal tolerability and safety of Meloxicam

  2001cited by this paper
• A critique of the 2000 update of the American College of Rheumatology recommendations for management of hip and knee osteoarthritis.

  2001cited by this paper
• Use of acetaminophen in the treatment of osteoarthritis in patients with liver disease: comment on the 2000 update of the American College of Rheumatology recommendations for management of hip and knee osteoarthritis.

  2001cited by this paper
• Relative Risk of Upper Gastrointestinal Complications among Users of Acetaminophen and Nonsteroidal Anti-Inflammatory Drugs

  2001cited by this paper
• Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells*

  2001cited by this paper
• Safety and efficacy of meloxicam 7.5 mg in the treatment of osteoarthritis in Thai patients.

  2001influential reference
• Concerns about the methodology used in developing the 2000 update of the American College of Rheumatology recommendations for management of hip and knee osteoarthritis.

  2001cited by this paper
• Evidence based medicine: the median is not the message.

  2001cited by this paper
• Should Celecoxib Be Contraindicated in Patients Who Are Allergic to Sulfonamides?

  2001influential reference
• COX-2 selectivity and inflammatory processes.

  2000influential reference
• Osteoarthritis pain and its treatment

  2000cited by this paper
• Clinical Judgement: Evidence in Practice

  2000cited by this paper
• Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

  2000influential reference
• Safety and efficacy of meloxicam in the treatment of osteoarthritis: a 12-week, double-blind, multiple-dose, placebo-controlled trial. The Meloxicam Osteoarthritis Investigators.

  2000influential reference
• Effectiveness of Manual Physical Therapy and Exercise in Osteoarthritis of the Knee

  2000cited by this paper
• The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19,087 patients in general practice in England: cohort study.

  2000cited by this paper
• The long-term effects of non-steroidal anti-inflammatory drugs in osteoarthritis of the knee: a randomized placebo-controlled trial.

  2000cited by this paper
• Clinical evaluation in the rheumatic diseases

  2000cited by this paper
• Glucosamine and chondroitin for treating symptoms of osteoarthritis: evidence is widely touted but incomplete.

  2000cited by this paper
• Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

  2000influential reference
• Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study Group.

  2000cited by this paper
• The Bristol 'OA500 study': progression and impact of the disease after 8 years.

  2000cited by this paper
• The Marshall R. Urist Young Investigator Award. Orthopaedic applications of gene therapy. From concept to clinic.

  2000cited by this paper
• A New Cyclooxygenase‐2 Inhibitor, Rofecoxib (VIOXX®), Did Not Alter the Antiplatelet Effects of Low‐Dose Aspirin in Healthy Volunteers

  2000cited by this paper
• Human Bone Morphogenetic Protein Allografting for Reconstruction of Femoral Nonunion

  2000cited by this paper
• Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis.

  2000cited by this paper
• Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind study.

  2000cited by this paper
• Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update

  2000cited by this paper
• Gene therapy for osteoarthritis: new perspectives for the twenty-first century.

  2000cited by this paper
• Paracetamol-inhibitable COX-2.

  2000cited by this paper
• Percutaneous absorption of topically applied NSAIDS and other compounds: Role of solute properties, skin physiology and delivery systems

  1999cited by this paper
• Reduced utilization and cost of primary care clinic visits resulting from self-care education for patients with osteoarthritis of the knee.

  1999cited by this paper
• An in vivo analysis of the effectiveness of the osteoarthritic knee brace during heel-strike of gait.

  1999cited by this paper
• Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.

  1999influential reference
• Knee replacement surgery for osteoarthritis: effectiveness, practice variations, indications and possible determinants of utilization.

  1999cited by this paper
• COX-2 inhibitors.

  1999cited by this paper
• Outcomes of total hip and knee replacement: preoperative functional status predicts outcomes at six months after surgery.

  1999cited by this paper
• Incidence and risk factors for radiographic knee osteoarthritis in middle-aged women: the Chingford Study.

  1999cited by this paper
• Selective COX-2 inhibition.

  1999cited by this paper
• Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate.

  1999cited by this paper
• Arthritis: new agents herald more effective symptom management.

  1999cited by this paper
• Vitamins and arthritis. The roles of vitamins A, C, D, and E.

  1999cited by this paper
• Plain radiography as an outcome measure in clinical trials involving patients with knee osteoarthritis.

  1999cited by this paper
• Effects of joint lavage and steroid injection in patients with osteoarthritis of the knee: results of a multicenter, randomized, controlled trial.

  1999cited by this paper
• Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis.

  1999influential reference
• Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.

  1999cited by this paper
• Meloxicam, 15 mg/day, spares platelet function in healthy volunteers

  1999cited by this paper
• Exercise in the treatment of osteoarthritis.

  1999cited by this paper
• Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to nonsteroid antiinflammatory drugs.

  1999cited by this paper
• Serum markers of articular cartilage damage and repair.

  1999cited by this paper
• Osteoarthritis of the knee: isokinetic quadriceps exercise versus an educational intervention.

  1999cited by this paper
• Gastrointestinal safety profile of meloxicam: a meta-analysis and systematic review of randomized controlled trials.

  1999influential reference
• Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial.

  1999cited by this paper
• Synovial fluid markers in osteoarthritis.

  1999cited by this paper
• The role of nitric oxide in articular cartilage damage.

  1999cited by this paper
• Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: a randomized, double-blind, placebo-controlled study.

  1999cited by this paper
• Hyaluronic acid in the treatment of osteoarthritis of the knee.

  1999cited by this paper
• A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group.

  1999cited by this paper
• In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression.

  1999cited by this paper
• Effectiveness of home exercise on pain and disability from osteoarthritis of the knee: a randomised controlled trial

  1999cited by this paper
• Topical diclofenac versus placebo: a double blind, randomized clinical trial in patients with osteoarthritis of the knee.

  1999cited by this paper
• Current concepts of the actions of paracetamol (acetaminophen) and NSAIDs

  1999cited by this paper
• Magnetic resonance imaging of osteoarthritis.

  1999cited by this paper
• The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis. Phase II Rofecoxib Rheumatoid Arthritis Study Group.

  1999cited by this paper
• Effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a systematic review of randomized clinical trials.

  1999cited by this paper
• Superior responsiveness of the pain and function sections of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) as compared to the Lequesne-Algofunctional Index in patients with osteoarthritis of the lower extremities.

  1999cited by this paper
• Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids.

  1999cited by this paper
• Determinants of pain severity in knee osteoarthritis: effect of demographic and psychosocial variables using 3 pain measures.

  1999cited by this paper
• COX-1-sparing NSAIDs--is the enthusiasm justified?

  1999cited by this paper
• Beyond disability: measuring the social and personal consequences of osteoarthritis.

  1999cited by this paper
• Comparison of the responsiveness and relative effect size of the western Ontario and McMaster Universities Osteoarthritis Index and the short-form Medical Outcomes Study Survey in a randomized, clinical trial of osteoarthritis patients.

  1999cited by this paper
• Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2.

  1999cited by this paper
• Immunologic tolerability profile of celecoxib.

  1999cited by this paper
• A randomized trial of acupuncture as an adjunctive therapy in osteoarthritis of the knee.

  1999cited by this paper
• Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.

  1999cited by this paper
• The relationship of anxiety and depression with self-reported knee pain in the community: data from the Baltimore Longitudinal Study of Aging.

  1999cited by this paper
• Lower body osteoarticular pain and dose of analgesic medications in older disabled women: the Women's Health and Aging Study.

  1999cited by this paper
• Osteoarthritis: time to shift the paradigm

  1999cited by this paper
• Prevalence and treatment of pain in older adults in nursing homes and other long-term care institutions: a systematic review.

  1999cited by this paper
• Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects.

  1998cited by this paper
• Where does it hurt? Pain localization in osteoarthritis of the knee.

  1998cited by this paper

• Osteoarthritis in People with Multiple Sclerosis: A Systematic Review and Meta-Analysis

  2024cites this paper
• Osteoarthritis.

  2023cites this paper
• Treatment of rheumatic musculoskeletal disorders

  2023cites this paper
• Combined tribological and bactericidal effect of nanodiamonds as potential lubricant for artificial joints.

  2019cites this paper
• The effect of Glycirrhiza globra on osteoarthritis , suppress TNF-a , IL-1 b , Cox-2 , iNOS gene expression and prostaglandin E 2 and nitric oxide production in particular chondrocytes and monocyte / macrophages

  2018cites this paper
• Gastrointestinal Complications of Antirheumatic Drugs

  2017cites this paper
• Oxaprozin-Loaded Lipid Nanoparticles towards Overcoming NSAIDs Side-Effects

  2016cites this paper
• Therapeutic Effects of Ribunucleinate (Ribonucleotides) in Immuno-Inflammatory and Arthritic Diseases.

  2015influential citation
• Therapeutics of Ibuprofen in Rheumatic and Other Chronic and Painful Diseases

  2015cites this paper
• Gastrointestinal Adverse Reactions from Ibuprofen

  2015cites this paper
• Osteoarthritis of the hand I: aetiology and pathogenesis, risk factors, investigation and diagnosis

  2014cites this paper
• The investigation and measurement of quality of sleep in individuals with osteoarthritis in Taiwan : a cross-sectional survey

  2013cites this paper
• Green-lipped mussel (Perna canaliculus) extract efficacy in knee osteoarthritis and improvement in gastrointestinal dysfunction: a pilot study

  2012cites this paper
• Osteoarthritis of the knee and hip. Part II: therapy with ibuprofen and a review of clinical trials

  2012cites this paper
• Osteoarthritis of the knee and hip. Part I: aetiology and pathogenesis as a basis for pharmacotherapy

  2012influential citation
• Efficacy and safety of two generic copies of nimesulide in patients with low back pain or knee osteoarthritis.

  2011cites this paper
• Efficacy and safety of two generic copies of nimesulide in patients with low back pain or knee osteoarthritis Efficacia e sicurezza di due copie generiche di nimesulide nei pazienti che soffrono di dolore lombare o artrosi del ginocchio

  2009cites this paper
• Ibuprofen: pharmacology, efficacy and safety

  2009cites this paper
• Review of the pharmaceutical properties and clinical effects of the topical NSAID formulation, diclofenac epolamine

  2008cites this paper
• Review of the pharmaceutical properties and clinical effects of the topical NSAID formulation , diclofenac epolamine

  2008cites this paper
• Chapter 18 Gastrointestinal Complications of Anti-Rheumatic Drugs

  2008cites this paper
• Management of chronic musculoskeletal pain in the Elderly: Opinions on oral medication use

  2008cites this paper
• Arthritic disease suppression and cartilage protection with glycosaminoglycan polypeptide complexes (Peptacans) derived from the cartilage extracellular matrix: a novel approach to therapy

  2006cites this paper
• Introduction — The coxib controversies

  2005cites this paper
• Clinical applications of nimesulide in pain, arthritic conditions and fever

  2005cites this paper
• The use of NSAIDs in rheumatic disorders 2005: a global perspective

  2005influential citation
• Osteoarthritis: symptoms, signs and source of pain

  2004influential citation
• The impatient patient: a personal view of osteoarthritis

  2004influential citation
• Combination anti-inflammatory therapy: synergism in rats of NSAIDs/corticosteroids with some herbal/animal products

  2003cites this paper